Lightcalls.com
 

Start It, take a bribe for It & Ma...

Start It, take a bribe for It & Make a Mint: 20 Wealth Creating hiddens for Business Owners

By Joe John Duran

People have affection for the idea of running their have a title to businesses. They imagine creating their confess work environment, making unlimited amounts of cash and working on their have a title to terms. That's why more than single in kind million new businesses are formed each year in the United States alone. Unfortunately, the sad reality is that half of these businesses will fail within brace years, usually because the institutor was operating under some misguided beliefs.

The three greatest in number deadly myths of business success

Deadly Myth #1: "If you build it, they will come"

This mantra from the movie "Field of Dreams" illustrates single of the biggest businesskilling misconceptions. Many business holders spend countless hours designing pamphlets or working on the examine of their logos, but remarkably little time identifying for what reason they'll actually reach their potential customers and procure them to buy their effects or services. Why? Because they believe customers will simply pour in.

Deadly Myth #2: Doing what you have affection for is the key to success



There's a immense difference between making great bread and running a great bakery. greatest in number successful entrepreneurs enjoy running their business more than they have sexual delight with making its product or performing its service.

Deadly Myth #3: A profitable business is a lucky business.

Tomorrow's profits won't pay today's bills. even now sadly, countless entrepreneurs only realize at the last minute that they don't have enough cash in their account to make payroll or schism Many businesses would be saved if the proprietors simply understood the following fundamental principle: Cash deliquesce is the lifeblood of any independent business-profits are not!

Start It, betray It & Make a Mint (Wiley and Son 2004) is a straightforward guide to auspicious entrepreneurship. Organized around 20 "vital secrets" the main division covers all functional aspects of running a business, including building an effective improvement creating winning products, and the art of selling and marketing. Each section contains examples, instructional parables, insight gleaned from the dozens of fortunate entrepreneurs author Joe John Duran interviewed, and Duran's acknowledge practical advice and lessons gained from building and selling a billion-dollar financial services company of his own

All of the take rises from Start It, Sell It & Make a Mint are donated to a foundation dedicated to empowering and teaching entrcpreneurship to underprivileged youth in the US, primary in low-income communities. The part is available at www.amazon.com. Or for more information, go on foot to www.startit sellit.com, where you'll find independent tips, tools, and articles, and can sign up for a unrestrained Start it, Sell It question at issue Solver newsletter.

Joe John Duran, CFA, originateed Alchemy Capital, a corporation dedicated to helping independent businesses germinate and prosper, in 2002. The previous year, he sold his company Centurion Capital Management to General Electrics GE Financial for a "stunning price" (Hamilton Leach, Investment stranges October 2001).

Duran has been interviewed according to publications such as USA Today and Investment stranges has spoken at hundreds of investment interviews and written dozens of articles for publications like Financial Planning Magazine and The beholds Angeles Times.

Compiled by Michelle McRae, Editor

Copyright Institute of Chartered Accountants of British Columbia Oct 2004

Provided according to ProQuest Information and Learning Company. All rights Reserved



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.